However, CD147's presence may be deemed necessary since its endothelial genetic deletion (such as in the scenario of gene knockout treatments) promotes alterations with regards to the blood-brain barrier, implicating the absence of CD147 in the pathogenesis of Alzheimer’s disease [51]. The gene discussed is BSG; the disease is early-onset autosomal dominant Alzheimer disease.